ERBB2 and breast cancer: We have previously characterized the immune cell profiles in HER2-positive breast cancer and have shown that especially, high densities of cytotoxic T cells and M1-like macrophages in the centre of the tumour region are strong independent prognostic markers surpassing all the studied baseline factors for survival [14, 15].